OrbiMed’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1M | Hold |
6,059,528
|
|
||||
|
2025
Q1 | $15.9M | Hold |
6,059,528
|
|
||||
|
2024
Q4 | $21.5M | Hold |
6,059,528
|
|
||||
|
2024
Q3 | $27.6M | Buy |
6,059,528
+500,000
|
|
||||
|
2024
Q2 | $24.2M | Hold |
5,559,528
|
|
||||
|
2024
Q1 | $27.9M | Hold |
5,559,528
|
|
||||
|
2023
Q4 | $34.9M | Hold |
5,559,528
|
|
||||
|
2023
Q3 | $39.6M | Hold |
5,559,528
|
|
||||
|
2023
Q2 | $56.7M | Hold |
5,559,528
|
|
||||
|
2023
Q1 | $50.4M | Hold |
5,559,528
|
|
||||
|
2022
Q4 | $39.9M | Buy |
5,559,528
+762,380
|
|
||||
|
2022
Q3 | $31.3K | Hold |
4,797,148
|
|
||||
|
2022
Q2 | $23.1K | Hold |
4,797,148
|
|
||||
|
2022
Q1 | $27.2M | Hold |
4,797,148
|
|
||||
|
2021
Q4 | $24.1M | Hold |
4,797,148
|
|
||||
|
2021
Q3 | $31.9M | Hold |
4,797,148
|
|
||||
|
2021
Q2 | $29.3M | Hold |
4,797,148
|
|
||||
|
2021
Q1 | $31.9M | Hold |
4,797,148
|
|
||||
|
2020
Q4 | $25.4M | Hold |
4,797,148
|
|
||||
|
2020
Q3 | $35.7M | Hold |
4,797,148
|
|
||||
|
2020
Q2 | $35.3M | Buy |
4,797,148
+1,387,283
|
|
||||
|
2020
Q1 | $25.2M | Hold |
3,409,865
|
|
||||
|
2019
Q4 | $19.3M | Hold |
3,409,865
|
|
||||
|
2019
Q3 | $20M | Hold |
3,409,865
|
|
||||
|
2019
Q2 | $10.9M | Hold |
3,409,865
|
|
||||
|
2019
Q1 | $10.2M | Hold |
3,409,865
|
|
||||
|
2018
Q4 | $12.8M | Hold |
3,409,865
|
|
||||
|
2018
Q3 | $20M | Hold |
3,409,865
|
|
||||
|
2018
Q2 | $19.3M | Hold |
3,409,865
|
|
||||
|
2018
Q1 | $42.3M | Hold |
3,409,865
|
|
||||
|
2017
Q4 | $41.2M | Buy |
+3,409,865
|
|